Skip to main content
Julio Hajdenberg, MD, Hematology, Cambridge, MA, Veterans Affairs Boston Healthcare System - Jamaica Plain

JulioJHajdenbergMDFACP(He/Him)

Hematology Cambridge, MA

Hematologic Oncology

Senior Medical Director Black Diamond Therapeutics, Cambridge MA

Dr. Hajdenberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hajdenberg's full profile

Already have an account?

Education & Training

  • Massachusetts Institute of Technology
    Massachusetts Institute of TechnologyCertification, Drug and Medical Device Development, 2022
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1994 - 1997
  • Cooper Medical School of Rowan University/Cooper University Hospital
    Cooper Medical School of Rowan University/Cooper University HospitalResidency, Internal Medicine, 1991 - 1994
  • University of Buenos Aires
    University of Buenos AiresClass of 1990

Certifications & Licensure

  • NH State Medical License
    NH State Medical License 1996 - Present
  • MA State Medical License
    MA State Medical License 1994 - 2026
  • FL State Medical License
    FL State Medical License 1997 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Top Doctors Castle Connolly, 2016-2022
  • Health Care Provider of the Year Leukemia Lymphoma Society, 2016

Publications & Presentations

PubMed

Press Mentions

  • Reader Responses: Can I Start Cytoreductive Therapy in a Patient with Low-Risk Polycythemia Vera?
    Reader Responses: Can I Start Cytoreductive Therapy in a Patient with Low-Risk Polycythemia Vera?December 1st, 2020
  • Reader Responses: How Would You Treat This Patient with JAK2-Positive Essential Thrombocythemia?
    Reader Responses: How Would You Treat This Patient with JAK2-Positive Essential Thrombocythemia?November 30th, 2020
  • Reader Responses: Is Hypogammaglobulinemia Alone an Indication for Treatment for CLL?
    Reader Responses: Is Hypogammaglobulinemia Alone an Indication for Treatment for CLL?November 1st, 2020
  • Join now to see all

Committees

  • Member, IDEA/ASCO 2020 - 2022
  • Member, Prostate Cancer Advisory Committee/State of Florida 2016 - 2021

Professional Memberships

Other Languages

  • Spanish

Hospital Affiliations

Industry Relationships

  • Senior Medical Director, Black Diamond Therapeutics2021 - Present